MCCULLOGH ROBERT F JR

CIK 00013415971 companyCHICAGO, IL

SEC Profile

Transactions

Companies

Filings

CIK

0001341597

Recent Transactions

34 trades

Award
Medite Cancer Diagnostics, Inc.
Common Stock
2013-05-20$0.02/sh+162,500,000→ 167,524,501 total
Purchase
Medite Cancer Diagnostics, Inc.
Common Stock
2012-06-26$0.02/sh+1,301,353→ 5,024,501 total
Purchase
Medite Cancer Diagnostics, Inc.
Common Stock
2012-02-14$0.01/sh+2,187,500→ 3,723,148 total
Purchase
Medite Cancer Diagnostics, Inc.
Common Stock, $ .001 par value
2009-04-29$0.25/sh+400,000→ 966,417 total
Exercise of In-Money
Medite Cancer Diagnostics, Inc.
Common Stock, $ .001 par value
2009-04-29$0.25/sh+37,500→ 1,028,917 total
Exercise/Conversion
Medite Cancer Diagnostics, Inc.
Common stock warrant
2009-04-29−25,000→ 0 total
Exercise/Conversion
Medite Cancer Diagnostics, Inc.
Common Stock, $ .001 par value
2009-04-29$0.25/sh+10,000→ 1,051,417 total
Exercise of In-Money
Medite Cancer Diagnostics, Inc.
Common stock warrant
2009-04-29−12,500→ 0 total
Exercise of In-Money
Medite Cancer Diagnostics, Inc.
Common stock warrant
2009-04-29−37,500→ 0 total
Exercise/Conversion
Medite Cancer Diagnostics, Inc.
Common stock warrant
2009-04-29−400,000→ 0 total
Exercise/Conversion
Medite Cancer Diagnostics, Inc.
Common stock warrant
2009-04-29−10,000→ 0 total
Exercise/Conversion
Medite Cancer Diagnostics, Inc.
Common Stock, $ .001 par value
2009-04-29$0.25/sh+25,000→ 991,417 total
Exercise of In-Money
Medite Cancer Diagnostics, Inc.
Common Stock, $ .001 par value
2009-04-29$0.25/sh+12,500→ 1,041,417 total
Purchase
Medite Cancer Diagnostics, Inc.
Common Stock, $ .001 par value
2009-04-24$0.34/sh+5,000→ 566,417 total
Purchase
Medite Cancer Diagnostics, Inc.
Common Stock, $.001 par value
2009-04-23$0.35/sh+5,000→ 1,242,950 total
Purchase
Medite Cancer Diagnostics, Inc.
Common Stock, $ .001 par value
2009-04-17$0.41/sh+4,000→ 561,417 total
Purchase
Medite Cancer Diagnostics, Inc.
Common Stock, $.001 par value
2009-04-13$0.42/sh+3,000→ 1,237,950 total
Purchase
Medite Cancer Diagnostics, Inc.
Common Stock, $ .001 par value
2009-04-10$0.45/sh+5,000→ 557,417 total
Purchase
Medite Cancer Diagnostics, Inc.
Common Stock, $.001 par value
2009-04-09$0.43/sh+60,800→ 1,234,950 total
Purchase
Medite Cancer Diagnostics, Inc.
Common Stock, $ .001 par value
2009-04-09$0.45/sh+5,000→ 552,417 total
Purchase
Medite Cancer Diagnostics, Inc.
Common Stock, $.001 par value
2009-04-08$0.44/sh+10,000→ 1,174,150 total
Purchase
Medite Cancer Diagnostics, Inc.
Common Stock, $.001 par value
2009-04-06$0.44/sh+18,000→ 1,164,150 total
Purchase
Medite Cancer Diagnostics, Inc.
Common Stock, $.001 par value
2009-04-03$0.45/sh+5,000→ 1,146,150 total
Purchase
Medite Cancer Diagnostics, Inc.
Common Stock, $.001 par value
2009-04-02$0.45/sh+1,000→ 1,141,150 total
Purchase
Medite Cancer Diagnostics, Inc.
Common stock, $.001 par value
2009-04-02$0.47/sh+3,000→ 547,417 total
Purchase
Medite Cancer Diagnostics, Inc.
Common Stock, $.001 par value
2009-04-01$0.44/sh+22,000→ 1,140,150 total
Purchase
Medite Cancer Diagnostics, Inc.
Common Stock, $.001 par value
2009-03-25$0.48/sh+25,000→ 1,118,150 total
Purchase
Medite Cancer Diagnostics, Inc.
Common Stock, $.001 par value
2009-03-20$0.56/sh+40,000→ 1,093,150 total
Purchase
Medite Cancer Diagnostics, Inc.
Common Stock, $.001 par value
2009-03-19$0.55/sh+7,500→ 1,053,150 total
Purchase
Medite Cancer Diagnostics, Inc.
Common Stock, $.001 par value
2009-03-18$0.51/sh+30,000→ 1,045,650 total
Purchase
Medite Cancer Diagnostics, Inc.
Common Stock, $.001 par value
2009-03-16$0.52/sh+11,000→ 1,015,650 total
Purchase
Medite Cancer Diagnostics, Inc.
Common Stock, $.001 par value
2009-03-13$0.55/sh+10,000→ 1,004,650 total
Award
Medite Cancer Diagnostics, Inc.
Common Stock, $ .001 par value
2009-03-11+59,459→ 1,110,876 total
Purchase
Medite Cancer Diagnostics, Inc.
Common Stock, $0.001 par value
2007-12-28$2.30/sh+7,500→ 410,750 total

Companies

Medite Cancer Diagnostics, Inc.
Director, CEO and CFO

Recent Filings

Address

C/O CYTOCORE, INC. 414 N. ORLEANS ST. SUITE 510

CHICAGO, IL, 60654

View on SEC.gov